Page 7 - Indian Pharma Companies

BDR Pharma introduces prostate cancer drug with enhanced strength

The company has introduced the medication, under the brand name BDENZA 160mg, at Rs 6,300 for a strip of seven tablets

Russia-Ukraine crisis: Indian pharma exporters in wait and watch mode

An official of Dr Reddy's Laboratories said they are closely monitoring the developments and ensuring the well-being of their staff in that region is the first and foremost priority

Pharma company Venus Remedies joins AMR Industry Alliance

AMR Industry Alliance is the largest private-sector coalition working towards curbing AMR through a coordinated and multipronged response

Demand tonic to spur pharma growth in FY22: A CRISIL analysis

But exports to stay under the weather; credit outlook remains stable

AIMIL Pharma launches ayurveda-based beauty product

The product -- Ayouthveda -- has been prepared by adding time-tested herbs

Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore

The drug firm on Monday reported a decline in its consolidated net profit

Cipla posts 7% year-on-year rise in Q2 PAT, riding on 10% revenue growth

Sequentially, however, the company has posted muted growth-revenue growth of 0.3%, and a PAT decline of 0.5%. Ebitda dipped sequentially too, by 9%

Back to old normal: Pharma industry returns to pre-pandemic growth level

In this first instalment of a four-part series on how some of the defining numbers in key sectors are springing back to the pre-pandemic level, Sohini Das looks at India's pharmaceutical sector

PharmEasy acquires Medlife, becomes India's largest e-pharma company

As Medlife discontinues operations, its users will move seamlessly to Pharmeasy, which will now serve 2 million households every month

Covid-19 crisis: Pharma majors step up support to affected employees

A company spokesperson said this benefit will be over and above the existing group term insurance

Covid-19: Remdesivir production scaled up to 11.9 million vials per month

All seven domestic licensed manufacturers of Remdesivir have scaled up production from 3.8 million vials per month to nearly 11.9 million vials per month, following government directives

Dr Reddy's Laboratories consolidated net profit dips 29% to Rs 557 crore

Dr Reddy's Laboratories on Friday reported 29 per cent decline in consolidated net profit at Rs 557 crore for the fourth quarter ended March 31, 2021. The Hyderabad-based drug major had posted a net profit of Rs 781 crore in January-March period of 2019-20. Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20, Dr Reddy's Laboratories said in a regulatory filing. For 2020-21 fiscal year, the company posted a consolidated net profit of Rs 1,952 crore as against Rs 2,026 crore in 2019-20. Net sales increased to Rs 18,420 crore during the last fiscal year as compared with Rs 16,357 crore in 2019-20. "In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline," Dr Reddy's Laboratories Co-Chairman and MD G V Prasad said. The company is prioritising its efforts to launch Sputnik V vaccine across India while working on the development and ...

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug

Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Dr Reddy's stock sheds 4% as Sputnik V pricing, competition weigh

Access to the private market, international sales are other factors that will impact margins

Remdesivir output to be ramped up as Covid-19 cases rise sharply

Zydus had recently also slashed prices of its remdesivir brand Remdac to Rs 899 per dose

Dr Reddy's expects Covid vaccine to get nod from India in next few weeks

Pharma major Dr Reddy's Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said

Adar Poonawalla rents London mansion for $69,000 a week, says report

The mansion is one of the largest residences in the neighborhood and measures about 25,000 square feet (2,322 square meters), the equivalent of about 24 average English homes

Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin